I know I’m preaching to the choir here to some extent, but just stop and think: how could you or anyone KNOW what was contained in ANY of Gates’ fetishistic concoctions? Do you have the ability to run a chemical assay? Of course not. You are being asked to trust some of the most heinous criminals to ever live – lying liars who lie, and have as their open, explicit goal the reduction of the human population by something like 85%.
Bill and Melinda Gates already clandestinely injected sterilants into millions of Kenyans under the guise of tetanus shots. When caught, they lyingly claimed that there was a “contamination” at the production facility. Yeah. Riiiight.
Here is a firm that is totally in bed with the Bill and Melinda Gates Foundation producing microneedle patch slow-release drug systems. Note the ominous reference to “patient compliance” as a selling point.
Marry this technology to the ultraviolet fluorescing barcode tattoo (the aptly named Luciferase), and you’ve got a tracking system, banking modality, AND a sterilant. All in one.
Who we are:
Micron develops pharmaceutical products, based on its proprietary microneedle patch technology, that are designed to provide enhanced vaccines and proprietary drugs efficacy, superior patient compliance, and simplified administration, distribution, and storage logistics.
Micron attends WHO meeting of experts on microneedle patches for measles vaccination
GENEVA, April 23, 2018 – The World Health Organization (WHO) invited Micron Biomedical, Inc. (Micron) to participate in a workshop on the development of microneedle patches for vaccination against measles. This meeting is taking place at the WHO headquarters in Geneva, Switzerland, April 23-24, 2018 and gathers experts from around the world on measles and microneedle patch technology. Attendees include members of the Bill & Melinda Gates Foundation (BMGF), WHO, Doctors Without Borders (MSF), Centers for Disease Control and Prevention (CDC), PATH, vaccine manufacturers, and microneedle patch companies. Micron will present its ongoing work on the development of a measles and rubella microneedle patch funded by BMGF and UNICEF.